ANALYSIS: Disclosures by private owner EQT suggest it is starting to think about an exit, possibly even an IPO.
As Parliament mulls granting an online sports betting monopoly to UK-listed Entain, the costs as well as the benefits are becoming more apparent.
ANALYSIS: The US imposition of tariffs makes no economic sense – and neither does retaliation.
ANALYSIS: The arguments on Crown asset sales are straightforward, so why not talk about it?
ANALYSIS: Minority shareholders in NZX-listed Millennium & Copthorne have an awkward decision to make.
ANALYSIS: Comments from the biotech’s biggest – and soon to be ex – customer reveal a different perspective on its clinical research.
ANALYSIS: Allowing KiwiSaver funds greater exposure to private assets will be good for fund managers. The benefits for investors are more dubious.
ANALYSIS: The solar system provider’s failure could taint its managers and investors, particularly BlackRock.
ANALYSIS: A glimpse into the venture capital investor’s financials reveals some pros and cons.
ANALYSIS: As Vital Healthcare revives a restructuring scheme, directors of its external manager seem particularly antsy about their independence.